Log In
BCIQ
Print this Print this
 

DermaVir Patch (LC002)

  Manage Alerts
Collapse Summary General Information
Company Genetic Immunity LLC
DescriptionSynthetic plasmid DNA-containing vaccine administered topically by the dendritic cell-targeting DermaPrep transdermal delivery device
Molecular Target HIV antigens
Mechanism of ActionImmunotherapy
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/08/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today